Investing
AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
© Reuters. FILE PHOTO: FILE PHOTO: Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) – AstraZeneca (NASDAQ:) said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.
The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications, the drugmaker said in a statement.
UK-based Quell will receive $85 million upfront from AstraZeneca, and is also eligible to receive over $2 billion for further development and commercialisation milestones, the company added.
Read the full article here
Barbara Corcoran: 5% Rate Would Make the Market Go Ballistic
Why Donald Trump’s Business-First Policies Trump Harris’ Consumer-Centric Approach
Not Backing up Your Phone? This is Why You Need to Start.
The App That Makes You Think Like a CEO
Swiss voters reject more powers for landlords on subletting By Reuters
How to Create a Unique Value Proposition (With Tips & Examples)
The DOJ Reportedly Wants Google to Sell Its Chrome Browser
Are You Missing These Hidden Warning Signs When Hiring?
7 Common Things You Should Never Buy New
This Founder Turned a Hangover Cure into Millions
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles6 days agoHow to Create a Unique Value Proposition (With Tips & Examples)
-
Side Hustles6 days agoThe DOJ Reportedly Wants Google to Sell Its Chrome Browser
-
Investing5 days agoAre You Missing These Hidden Warning Signs When Hiring?
-
Make Money5 days ago7 Common Things You Should Never Buy New
-
Investing7 days agoThis Founder Turned a Hangover Cure into Millions
-
Investing2 days agoThis All-Access Pass to Learning Is Now $20 for Black Friday
-
Side Hustles3 days agoApple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Passive Income2 days agoHow to Create a Routine That Balances Rest and Business Success